Tilray Brands, Inc. to Announce Second Quarter 2024 Financial Results on January 9, 2024
NEW YORK and LEAMINGTON, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; […]
Ascent Solar Technologies Inc. Achieves Spaceflight Heritage for its Space Solar PV Array Products on Momentus’ Vigoride-6 Mission
THORNTON, Colo., Dec. 21, 2023 (GLOBE NEWSWIRE) — Ascent Solar Technologies, (Nasdaq: ASTI) (“ASTI” or the “Company”), the leading U.S. […]
Pacira Appoints Frank D. Lee as Chief Executive Officer
— Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and Commercialization — — Paul J. […]
nCino and Salesforce Expand Strategic Partnership to Further Modernize the Financial Services Industry
Leaders in cloud innovation reinforce alliance to provide best-in-class solutions to the financial services industry by extending successful partnership to […]
Former Director of Security of the Israeli Defense Establishment Nir Ben Moshe Joining ParaZero
Ben Moshe is set to join ParaZero as a specialist advisor, utilizing his extensive network in defense and homeland security […]
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
NAUTILUS is the first and only pivotal clinical study to evaluate neuromodulation therapy for treating drug refractory idiopathic generalized epilepsy […]
NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
BELTSVILLE, Md., Dec. 21, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing […]
Save Foods: Nitrousink Commenced Controlled Trial for the Reduction of Greenhouse Gas Emissions
Neve Yarak, Israel, Dec. 21, 2023 (GLOBE NEWSWIRE) — Save Foods, Inc. (NASDAQ: SVFD) (FSE:80W), an agri-food tech leader, announced […]
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
Gilead purchased 15 million newly issued shares of common stock at a price of $1.4167 per share Following the close […]
SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
STAMFORD, Conn., Dec. 21, 2023 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe […]
